Muscle Growth-Promoting Peptides: How Do They Work?

[Disclaimer: All content provided on this website, including product information and articles, is intended exclusively for educational and informational purposes.]

Peptides are a class of biological molecules composed of short amino acid chains (2-100 amino acids). Recent scientific interest has focused on specific peptides that may influence muscle tissue development pathways.

These compounds have attracted attention for their potential to interact with biological mechanisms governing muscle protein synthesis, growth factor signaling, and tissue regeneration.

This article analyzes the current scientific evidence about peptides studied for muscle growth and recovery, exploring their proposed mechanisms and laboratory research applications.

The Science Behind Muscle Growth

Muscle growth (hypertrophy) represents a complex biological process governed by the delicate balance between muscle protein synthesis (MPS) and muscle protein breakdown (MPB).

In normal conditions, these processes remain balanced to maintain existing muscle mass. Hypertrophy occurs when protein synthesis consistently exceeds breakdown over time, resulting in net protein accretion and muscle enlargement.

Three primary factors regulate muscle development:

• Resistance Exercise serves as the most potent stimulus for muscle growth, creating mechanical tension that triggers molecular signaling cascades and elevates protein synthesis for hours after training.
• Nutritional Factors provide essential building blocks, particularly amino acids, needed to support protein synthesis. Adequate protein intake, especially sources rich in essential amino acids like leucine, maximizes the muscle-building response to exercise.
• Hormonal Regulators including testosterone, growth hormone (GH), and insulin-like growth factor-1 (IGF-1) influence muscle metabolism through specific signaling pathways. These hormones activate crucial molecular mechanisms including the PI3K-Akt, MAPK, and mTOR pathways—all potential targets for peptide research in laboratory settings.

Key Types of Muscle Growth-Promoting Peptides

Researchers have identified several categories of peptides that show potential for promoting muscle growth and recovery pathways through various mechanisms. These peptides interact with specific signaling cascades involved in protein synthesis, satellite cell activation, and tissue regeneration.

Growth Hormone-Related Peptides

Growth Hormone Secretagogues (GHS) consist of synthetic peptides designed to stimulate Growth Hormone (GH) secretion from the pituitary gland.

This category includes several important research compounds:

Growth Hormone-Releasing Peptides (GHRPs):

• GHRP-2 (Pralmorelin)
• GHRP-6
• Ipamorelin
• Hexarelin (Examorelin)
• Alexamorelin
• Other numbered GHRPs (GHRP-1, GHRP-3, GHRP-4, GHRP-5)

Growth Hormone Releasing Hormone (GHRH) analogues:

• Sermorelin
• Tesamorelin
• CJC-1293
• CJC-1295

Non-peptide GHS:

• Ibutamoren (MK-677) – A potent non-peptide GH secretagogue that acts via the ghrelin receptor pathway
• Other mimetics (Anamorelin, Lenomorelin, Macimorelin, Tabimorelin)

These compounds primarily function by binding to the Growth Hormone Secretagogue Receptor (GHS-R1a), creating a pathway distinct from natural GHRH.¹

Laboratory studies confirm their potent GH-stimulating effects, which subsequently increase Insulin-like Growth Factor-1 (IGF-1) production—the principal mediator of GH’s anabolic actions on tissues.²

Recent research suggests GHRPs may potentially exert direct tissue effects independent of GH secretion. In vitro studies have shown certain GHRPs can influence myoblast differentiation³ and modulate key protein synthesis pathways (PI3K, Akt, mTOR) in muscle cells.⁴

However, while these peptides reliably increase GH levels in laboratory settings, their direct impact on muscle hypertrophy mechanisms requires further investigation.

Insulin-Like Growth Factor-1 (IGF-1) and Variants

IGF-1 is a polypeptide hormone structurally similar to insulin that plays a critical role in muscle development and regeneration.

In research settings, several important variants are studied:

Key IGF-1 Variants:

• Native IGF-1 – Primarily liver-produced under GH stimulation
• Muscle-derived IGF-1 (mIGF-1) – Produced locally within muscle tissue
• Mechano-Growth Factor (MGF) – A splice variant upregulated after mechanical stimulation
• IGF-1 LR3 – A synthetic analog with reduced binding protein affinity and extended half-life

IGF-1 primarily functions through binding to the IGF-1 receptor (IGF-1R), activating crucial intracellular signaling pathways.² The PI3K/Akt/mTOR pathway drives protein synthesis while inhibiting degradation², while the MAPK pathway regulates cell proliferation and differentiation.⁵

Additionally, IGF-1 modulates satellite cell activity, promoting both proliferation and differentiation of these muscle stem cells.⁶

An important distinction exists between systemic (circulating) and local IGF-1 effects. Research suggests locally produced IGF-1 within muscle tissue, particularly in response to exercise or injury, may be more critical for adaptive hypertrophy than circulating IGF-1.⁶

Laboratory studies with cell cultures and animal models demonstrate the anabolic potential of these peptides, though translational research on muscle growth mechanisms continues to evolve.

BPC-157 (Body Protection Compound)

BPC-157 is a 15-amino acid peptide derived from a protective protein originally isolated from human gastric juice. This stable pentadecapeptide (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) has garnered significant research interest primarily for its tissue repair properties.

Key Mechanisms:

• Broad tissue repair and regeneration capabilities across multiple tissue types⁷
• Enhanced angiogenesis (formation of new blood vessels)⁷
• Upregulation of Growth Hormone Receptor expression⁷
• Promotion of cell migration and survival via FAK-paxillin pathway⁸
• Anti-inflammatory and cytoprotective effects⁹

In laboratory research, BPC-157 has demonstrated remarkable healing properties for skeletal muscle, tendons, ligaments, and the myotendinous junction.¹⁰

Studies in animal models show it can accelerate the repair of muscle injuries, including transections, crush injuries, and complete detachments.¹¹

It has also shown potential to counteract muscle wasting in disease models and reverse impaired healing caused by corticosteroid administration.¹²

While preclinical evidence for BPC-157’s healing effects is substantial, research has primarily focused on injury repair and gastrointestinal health rather than hypertrophy in healthy muscle. 

The peptide has reportedly advanced to clinical trials for conditions like Inflammatory Bowel Disease and Multiple Sclerosis, though studies specifically investigating effects on muscle growth in healthy subjects remain limited.

TB-500 (Thymosin Beta-4)

TB-500 is a synthetic version of Thymosin Beta-4 (Tβ4), corresponding to the N-terminally acetylated amino acid sequence 17-23 (Ac-LKKTETQ). Tβ4 is a naturally occurring 43-amino acid peptide found throughout mammalian tissues that plays a crucial role in regulating actin polymerization and cytoskeletal dynamics.

Key Mechanisms:

• Actin binding and enhancement of cell migration¹³
• Promotion of wound healing and tissue repair¹⁴
• Anti-inflammatory effects¹⁵
• Stimulation of angiogenesis¹³
• Modulation of stem/progenitor cell activity¹⁶

While full-length Tβ4 has been extensively studied for its tissue repair properties, research specific to TB-500 is more limited.

The unacetylated LKKTETQ sequence has been identified as the primary site responsible for actin binding and cell migration stimulation within Tβ4, and this fragment has been linked to angiogenesis promotion.¹⁷

In preclinical models of Duchenne Muscular Dystrophy, Tβ4 administration increased the number of regenerating muscle fibers, though this did not translate to functional strength improvements.¹⁸

Tβ4 has advanced to human clinical trials for applications like wound healing and organ repair, but studies specifically evaluating TB-500’s effects on muscle growth are scarce.

Most claims regarding its muscle-enhancing properties stem from extrapolation of Tβ4’s known functions rather than direct evidence.

Collagen Peptides

Collagen peptides, derived from the body’s most abundant structural protein, have demonstrated potential to support muscle development through several key mechanisms.

Key Mechanisms:

• Upregulation of gene expression in PI3K-Akt and MAPK signaling pathways
• Enhancement of protein synthesis while inhibiting muscle breakdown
• Increased abundance of proteins associated with contractile fibers
• Support for connective tissue that facilitates force transmission

A 2022 study published in Frontiers in Physiology found significantly upregulated expression of genes involved in key myocellular growth pathways following collagen peptide ingestion compared to placebo.¹⁹

Proteome analysis revealed 221 higher abundant proteins in subjects receiving collagen peptides versus only 44 proteins in the placebo group, with most upregulated proteins associated with contractile fiber development.²⁰

A systematic review and meta-analysis examining long-term (≥ 2 months) collagen peptide supplementation during resistance training indicated significant improvements in muscle size accrual and maximal strength in healthy adults.²¹

These findings suggest collagen peptides may interact with important signaling cascades that regulate protein synthesis and muscle adaptation, making them of interest for laboratory studies of muscle tissue development.

Pea Peptides

Plant-based peptides derived from pea protein represent an emerging area of research in muscle growth promotion.

Key Mechanisms:

• Increased testosterone and IGF-1 levels in experimental models
• Enhanced expression of IGF-1 receptors
• Increased phosphorylation of AMPK (AMP-activated protein kinase)
• Reduced myostatin expression (a negative regulator of muscle growth)
• Promotion of type II (fast-twitch) muscle fiber development²²

Research has identified specific oligopeptides within pea protein with notable effects on muscle cell proliferation. One particular sequence, LDLPVL (designated PP2), has demonstrated superior activity in laboratory studies examining muscle development pathways.

Studies combining pea peptide supplementation with resistance training have shown promising results in experimental models, including increased muscle thickness, greater wet weight of biceps brachii, and larger cross-sectional area of muscle fibers compared to exercise alone.²²

These findings suggest that specific plant-derived peptides may interact with key signaling pathways involved in muscle protein synthesis and cellular proliferation.

Takeaway and Future Directions

Despite growing interest in peptides for muscle growth research, a significant gap exists between theoretical potential and conclusive scientific evidence.

While mechanistic studies provide intriguing insights into how various peptides might influence muscle development pathways, comprehensive human clinical data remains limited for many of these compounds.

The field shows particular promise in several areas: Growth Hormone-related peptides have demonstrated clear GH-stimulating effects, IGF-1 variants play critical roles in local muscle signaling, and peptides like BPC-157 and TB-500 show remarkable tissue repair capabilities in preclinical models.

Naturally-derived options like pea and collagen peptides also offer interesting alternatives for studying muscle growth mechanisms.

As research advances, laboratories studying muscle development mechanisms will benefit from a clearer understanding of how these peptides interact with critical signaling pathways governing protein synthesis, satellite cell activation, and tissue regeneration.

Until more conclusive evidence emerges, the scientific community should approach claims about muscle-enhancing properties of peptides with appropriate caution while continuing to explore their legitimate research applications.

Referenced Sources

1. Sinha, D. K., Balasubramanian, A., Tatem, A. J., Rivera-Mirabal, J., Yu, J., Kovac, J., Pastuszak, A. W., & Lipshultz, L. I. (2020). Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Translational andrology and urology, 9(Suppl 2), S149–S159. https://doi.org/10.21037/tau.2019.11.30. ↩︎
2. Velloso C. P. (2008). Regulation of muscle mass by growth hormone and IGF-I. British journal of pharmacology, 154(3), 557–568. https://doi.org/10.1038/bjp.2008.153. ↩︎
3. Lim, C. J., Jeon, J. E., Jeong, S. K., Yoon, S. J., Kwon, S. D., Lim, J., Park, K., Kim, D. Y., Ahn, J. K., & Kim, B. W. (2015). Growth hormone-releasing peptide-biotin conjugate stimulates myocytes differentiation through insulin-like growth factor-1 and collagen type I. BMB reports, 48(9), 501–506. https://doi.org/10.5483/bmbrep.2015.48.9.258. ↩︎
4. Hu, R., Wang, Z., Peng, Q., Zou, H., Wang, H., Yu, X., Jing, X., Wang, Y., Cao, B., Bao, S., Zhang, W., Zhao, S., Ji, H., Kong, X., & Niu, Q. (2016). Effects of GHRP-2 and Cysteamine Administration on Growth Performance, Somatotropic Axis Hormone and Muscle Protein Deposition in Yaks (Bos grunniens) with Growth Retardation. PloS one, 11(2), e0149461. https://doi.org/10.1371/journal.pone.0149461. ↩︎
5. Yoshida, T., & Delafontaine, P. (2020). Mechanisms of IGF-1-Mediated Regulation of Skeletal Muscle Hypertrophy and Atrophy. Cells, 9(9), 1970. https://doi.org/10.3390/cells9091970. ↩︎
6. Song, Y. H., Song, J. L., Delafontaine, P., & Godard, M. P. (2013). The therapeutic potential of IGF-I in skeletal muscle repair. Trends in endocrinology and metabolism: TEM, 24(6), 310–319. https://doi.org/10.1016/j.tem.2013.03.004. ↩︎
7. Chang, C. H., Tsai, W. C., Hsu, Y. H., & Pang, J. H. (2014). Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts. Molecules (Basel, Switzerland), 19(11), 19066–19077. https://doi.org/10.3390/molecules191119066. ↩︎
8. Chang, C. H., Tsai, W. C., Lin, M. S., Hsu, Y. H., & Pang, J. H. (2011). The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of applied physiology (Bethesda, Md. : 1985), 110(3), 774–780. https://doi.org/10.1152/japplphysiol.00945.2010. ↩︎
9. Sikiric, P., Hahm, K. B., Blagaic, A. B., Tvrdeic, A., Pavlov, K. H., Petrovic, A., Kokot, A., Gojkovic, S., Krezic, I., Drmic, D., Rucman, R., & Seiwerth, S. (2020). Stable Gastric Pentadecapeptide BPC 157, Robert’s Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye’s Stress Coping Response: Progress, Achievements, and the Future. Gut and liver, 14(2), 153–167. https://doi.org/10.5009/gnl18490. ↩︎
10. Gwyer, D., Wragg, N. M., & Wilson, S. L. (2019). Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell and tissue research, 377(2), 153–159. https://doi.org/10.1007/s00441-019-03016-8. ↩︎
11. Staresinic, M., Japjec, M., Vranes, H., Prtoric, A., Zizek, H., Krezic, I., Gojkovic, S., Smoday, I. M., Oroz, K., Staresinic, E., Dretar, V., Yago, H., Milavic, M., Sikiric, S., Lovric, E., Batelja Vuletic, L., Simeon, P., Dobric, I., Strbe, S., Kokot, A., … Sikiric, P. (2022). Stable Gastric Pentadecapeptide BPC 157 and Striated, Smooth, and Heart Muscle. Biomedicines, 10(12), 3221. https://doi.org/10.3390/biomedicines10123221. ↩︎
12. Pevec, D., Novinscak, T., Brcic, L., Sipos, K., Jukic, I., Staresinic, M., Mise, S., Brcic, I., Kolenc, D., Klicek, R., Banic, T., Sever, M., Kocijan, A., Berkopic, L., Radic, B., Buljat, G., Anic, T., Zoricic, I., Bojanic, I., Seiwerth, S., … Sikiric, P. (2010). Impact of pentadecapeptide BPC 157 on muscle healing impaired by systemic corticosteroid application. Medical science monitor : international medical journal of experimental and clinical research, 16(3), BR81–BR88. ↩︎
13. Xing, Y., Ye, Y., Zuo, H., & Li, Y. (2021). Progress on the Function and Application of Thymosin β4. Frontiers in endocrinology, 12, 767785. https://doi.org/10.3389/fendo.2021.767785. ↩︎
14. Goldstein, A. L., Hannappel, E., Sosne, G., & Kleinman, H. K. (2012). Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert opinion on biological therapy, 12(1), 37–51. https://doi.org/10.1517/14712598.2012.634793. ↩︎
15. Spurney, C. F., Cha, H. J., Sali, A., Pandey, G. S., Pistilli, E., Guerron, A. D., Gordish-Dressman, H., Hoffman, E. P., & Nagaraju, K. (2010). Evaluation of skeletal and cardiac muscle function after chronic administration of thymosin beta-4 in the dystrophin deficient mouse. PloS one, 5(1), e8976. https://doi.org/10.1371/journal.pone.0008976. ↩︎
16. Xiong, Y., Mahmood, A., Meng, Y., Zhang, Y., Zhang, Z. G., Morris, D. C., & Chopp, M. (2012). Neuroprotective and neurorestorative effects of thymosin β4 treatment following experimental traumatic brain injury. Annals of the New York Academy of Sciences, 1270, 51–58. https://doi.org/10.1111/j.1749-6632.2012.06683.x. ↩︎
17. Ho, E. N., Kwok, W. H., Lau, M. Y., Wong, A. S., Wan, T. S., Lam, K. K., Schiff, P. J., & Stewart, B. D. (2012). Doping control analysis of TB-500, a synthetic version of an active region of thymosin β₄, in equine urine and plasma by liquid chromatography-mass spectrometry. Journal of chromatography. A, 1265, 57–69. https://doi.org/10.1016/j.chroma.2012.09.043. ↩︎
18. Spurney, C. F., Cha, H. J., Sali, A., Pandey, G. S., Pistilli, E., Guerron, A. D., Gordish-Dressman, H., Hoffman, E. P., & Nagaraju, K. (2010). Evaluation of skeletal and cardiac muscle function after chronic administration of thymosin beta-4 in the dystrophin deficient mouse. PloS one, 5(1), e8976. https://doi.org/10.1371/journal.pone.0008976. ↩︎
19. Centner, C., Jerger, S., Mallard, A., Herrmann, A., Varfolomeeva, E., Gollhofer, S., Oesser, S., Sticht, C., Gretz, N., Aagaard, P., Nielsen, J. L., Frandsen, U., Suetta, C., Gollhofer, A., & König, D. (2022). Supplementation of Specific Collagen Peptides Following High-Load Resistance Exercise Upregulates Gene Expression in Pathways Involved in Skeletal Muscle Signal Transduction. Frontiers in physiology, 13, 838004. https://doi.org/10.3389/fphys.2022.838004. ↩︎
20. Oertzen-Hagemann, V., Kirmse, M., Eggers, B., Pfeiffer, K., Marcus, K., de Marées, M., & Platen, P. (2019). Effects of 12 Weeks of Hypertrophy Resistance Exercise Training Combined with Collagen Peptide Supplementation on the Skeletal Muscle Proteome in Recreationally Active Men. Nutrients, 11(5), 1072. https://doi.org/10.3390/nu11051072. ↩︎
21. Bischof, K., Moitzi, A., & König, D. (2024). Impact of collagen peptide supplementation together with long-term resistance training on maximal strength and muscle size in healthy adults – A systematic review and meta-analysis. Current Issues in Sport Science (CISS). https://doi.org/10.36950/2024.4ciss002. ↩︎
22. Jia, S., Wu, Q., Wang, S., Kan, J., Zhang, Z., Zhang, X., Zhang, X., Li, J., Xu, W., Du, J., & Wei, W. (2022). Pea Peptide Supplementation in Conjunction With Resistance Exercise Promotes Gains in Muscle Mass and Strength. Frontiers in nutrition, 9, 878229. https://doi.org/10.3389/fnut.2022.878229. ↩︎

Author: Limitless Life Nootropics